Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-13

FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for a generic Clozapine product from Mylan Pharmaceuticals (ANDA201824). This action expands access to Clozapine for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

SUPPL AP for CLOZAPINE (CLOZAPINE)